Quick Answer
bioAffinity Technologies, Inc. reported Stockholders Equity of $7.28 million for fiscal year 2025.
bioAffinity Technologies, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.28M | +179.7% |
| 2024 | $2.60M | -46.4% |
| 2023 | $4.86M | -56.0% |
| 2022 | $11.04M | +169.9% |
| 2021 | -$15.79M | -4.8% |
| 2020 | -$15.07M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.90M | +185.2% | +516.7% |
| June 30, 2025 | -$2.14M | -162.2% | -248.4% |
| March 31, 2025 | $1.44M | -72.6% | -44.7% |
| December 31, 2024 | $2.60M | -46.4% | -16.6% |
| September 30, 2024 | $3.12M | -55.4% | -9.1% |
| June 30, 2024 | $3.43M | -57.6% | -34.7% |
| March 31, 2024 | $5.26M | -45.6% | +8.3% |
| December 31, 2023 | $4.86M | -56.0% | -30.6% |
- bioAffinity Technologies, Inc. showed an increase of +179.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, bioAffinity Technologies, Inc.’s stockholders equity has grown by 148.3% (from -$15.07 million to $7.28 million).
- The most recent figure is from bioAffinity Technologies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: